Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept.

[1]  James B. Mitchell,et al.  Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction , 2012, Proceedings of the National Academy of Sciences.

[2]  G. Illei,et al.  The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland. , 2012, Rheumatology.

[3]  G. Illei,et al.  TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice. , 2012, Oral diseases.

[4]  G. Illei,et al.  Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. , 2012, Oral diseases.

[5]  G. Dickson,et al.  Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity. , 2011, Nucleic acid therapeutics.

[6]  J. Bourke,et al.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study , 2011, The Lancet.

[7]  G. van Ommen,et al.  Systemic administration of PRO051 in Duchenne's muscular dystrophy. , 2011, The New England journal of medicine.

[8]  A. Torkamani,et al.  Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF , 2010, The Journal of Immunology.

[9]  A. Vissink,et al.  Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. , 2010, Arthritis and rheumatism.

[10]  P. Tak,et al.  Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome , 2009, Arthritis research & therapy.

[11]  S. Grey,et al.  CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells , 2009, Diabetes.

[12]  J. She,et al.  Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. , 2009, Experimental eye research.

[13]  X. Mariette,et al.  Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR‐ and type‐I IFN‐dependent and ‐independent pathways , 2008, European journal of immunology.

[14]  E. Lefèvre,et al.  BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. , 2008, Blood.

[15]  J. Pers,et al.  Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[16]  G. Burmester,et al.  Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study , 2006, Arthritis research & therapy.

[17]  X. Mariette,et al.  B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome , 2006, Arthritis research & therapy.

[18]  C. Lucchesi,et al.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Clackson,et al.  Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands , 2006, Gene Therapy.

[20]  Marjolein Vinkenoog,et al.  Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis , 2005, Arthritis research & therapy.

[21]  D. Greaves,et al.  deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. , 2005, Journal of immunology.

[22]  X. Mariette,et al.  Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome , 2004, The Journal of pathology.

[23]  C. Ware,et al.  ΔBAFF, an Alternate Splice Isoform That Regulates Receptor Binding and Biopresentation of the B Cell Survival Cytokine, BAFF* , 2003, Journal of Biological Chemistry.

[24]  X. Mariette,et al.  The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.

[25]  B. Sullenger,et al.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing , 2003 .

[26]  J. Mohler,et al.  Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents* , 2002, The Journal of Biological Chemistry.

[27]  J. Tschopp,et al.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. , 2002, The Journal of clinical investigation.

[28]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[29]  R. Kole,et al.  Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Cadman,et al.  Sjögren's Syndrome , 1953, Medicine illustrated.